These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 39176265)

  • 1. A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study.
    Zhong W; Yan L; Zhu Y; Shi L; He Y; Chen T; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1426960. PubMed ID: 39176265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
    Polaris Observatory Collaborators
    Lancet Gastroenterol Hepatol; 2023 Oct; 8(10):879-907. PubMed ID: 37517414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
    Hsu YC; Huang DQ; Nguyen MH
    Nat Rev Gastroenterol Hepatol; 2023 Aug; 20(8):524-537. PubMed ID: 37024566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.
    Zhang L; Jiang T; Yang Y; Deng W; Lu H; Wang S; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Yang L; Bi X; Lin Y; Lu Y; Jiang Y; Li M; Xie Y
    Front Immunol; 2022; 13():1112234. PubMed ID: 36685527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of long-term postpartum antiviral therapy in hepatitis B virus-infected mothers receiving prophylactic tenofovir disoproxil fumarate treatment.
    Feng Y; Yao N; Shi L; Zhu Y; Liu J; He Y; Zhao Y; Chen T
    Eur J Gastroenterol Hepatol; 2023 Feb; 35(2):212-218. PubMed ID: 36574312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers-a prospective cohort study of 417 cases.
    Wang X; Song A; Lin X; Lu J; Zheng S; Ma L; Ren S; Zheng Y; Chen X
    Front Immunol; 2022; 13():1031291. PubMed ID: 36311697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.
    Wang WX; Jia R; Gao YY; Liu JY; Luan JQ; Qiao F; Liu LM; Zhang XN; Wang FS; Fu J
    Front Immunol; 2022; 13():894410. PubMed ID: 35958609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.
    Chu JH; Huang Y; Xie DY; Deng H; Wei J; Guan YJ; Li GJ; Zeng YL; Yang JH; Chen XY; Shang J; Li JB; Gao N; Gao ZL
    J Viral Hepat; 2022 Sep; 29(9):765-776. PubMed ID: 35718996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection.
    Song A; Liu Y; Cao Z; Lu J; Ren S; Zheng S; Ma L; Hu Z; Lin X; Li H; Zheng Y; Chen X
    Front Immunol; 2022; 13():881321. PubMed ID: 35493501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB.
    Huang D; Wu D; Wang P; Wang Y; Yuan W; Hu D; Hu J; Wang Y; Tao R; Xiao F; Zhang X; Wang X; Han M; Luo X; Yan W; Ning Q
    J Hepatol; 2022 Jul; 77(1):42-54. PubMed ID: 35149125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.
    Kumar M; Abbas Z; Azami M; Belopolskaya M; Dokmeci AK; Ghazinyan H; Jia J; Jindal A; Lee HC; Lei W; Lim SG; Liu CJ; Li Q; Al Mahtab M; Muljono DH; Niriella MA; Omata M; Payawal DA; Sarin SK; Ségéral O; Tanwandee T; Trehanpati N; Visvanathan K; Yang JM; Yuen MF; Zheng Y; Zhou YH
    Hepatol Int; 2022 Apr; 16(2):211-253. PubMed ID: 35113359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare.
    Huang M; Gao Y; Yin X; Zhang X; Hao Y; Hu J; Liu Z
    BMC Infect Dis; 2021 Sep; 21(1):922. PubMed ID: 34488681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean HBsAg decline at week 24 of PEG-IFN-based treatment predicts subsequent rate of HBsAg clearance - suggesting a valuable endpoint for early development HBV trials.
    De Ridder F; Sonneveld MJ; Lenz O; Janssen HLA; Talloen W; Hansen BE
    J Viral Hepat; 2021 Nov; 28(11):1563-1569. PubMed ID: 34435408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China.
    Ren P; Li H; Huang Y; Jiang J; Guo S; Cao Z; Zhang C; Zhou T; Gan Q; Zhao S; Chen L; Guo Q; Cai W; Wang H; Hu P; Xie Q
    Antiviral Res; 2021 Oct; 194():105163. PubMed ID: 34389410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients.
    Broquetas T; Garcia-Retortillo M; Micó M; Canillas L; Puigvehí M; Cañete N; Coll S; Viu A; Hernandez JJ; Bessa X; Carrión JA
    World J Hepatol; 2020 Nov; 12(11):1076-1088. PubMed ID: 33312431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.
    Samadi Kochaksaraei G; Castillo E; Sadler MD; Seow CH; Barkema HW; Martin SR; Israelson H; Pinto J; Williams S; Aspinall AI; Stinton LM; Borman MA; Burak KW; Swain MG; Congly SE; Lee SS; Shaheen AA; Coffin CS
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1707-1716. PubMed ID: 33111382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on pegylated interferon augments hepatitis B surface antigen clearance
    Wu FP; Yang Y; Li M; Liu YX; Li YP; Wang WJ; Shi JJ; Zhang X; Jia XL; Dang SS
    World J Gastroenterol; 2020 Apr; 26(13):1525-1539. PubMed ID: 32308352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expert consensus on clinical cure (functional cure) of chronic hepatitis B].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):594-603. PubMed ID: 31594076
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.